VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Vistagen Therapeutics, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.20+0.00 (+1.55%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
26.5%
12M of 44M shares
Institutional holders
49
10 new, 16 sold out
Net institutional buying
-4M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Michael Kramarz | 4,383,508 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Commodore Capital LP | 4,244,590 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Bvf Partners L P/Il | 3,084,324 | 9.97% | 13G (passive) amendment | Dec 31, 2024 |
| Chen Yu | 2,960,404 | 6.70% | 13G (passive) amendment | Jun 30, 2026 |
| Great Point Partners, LLC | 2,055,834 | 6.59% | 13G (passive) amendment | Jun 30, 2025 |
| Ms. Lillian Nordahl | 2,055,834 | 6.28% | 13G (passive) amendment | Sep 30, 2025 |
| Stempoint Capital LP | 1,790,182 | 6.50% | 13G (passive) | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VTGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Commodore Capital LP | 2,788,620 | 6.28% | $630.23K | New | 0.04% |
| Vanguard Capital Management LLC | 1,574,200 | 3.55% | $355.77K | – | 0.00% |
| Two Sigma Investments, LP | 847,992 | 1.91% | $191.65K | +378,373 | 0.00% |
| Acadian Asset Management LLC | 794,579 | 1.79% | $178 | +204,916 | 0.00% |
| Renaissance Technologies LLC | 730,500 | 1.65% | $165.09K | +439,200 | 0.00% |
| Stempoint Capital LP | 616,749 | 1.39% | $17.28K | −616,749 | 0.00% |
| Ikarian Capital, LLC | 519,077 | 1.17% | $117.31K | – | 0.01% |
| AdvisorShares Investments LLC | 438,643 | 0.99% | $99.13K | +161,533 | 0.01% |
| Luminus Management LLC | 403,115 | 0.91% | $91.10K | +7,062 | 0.06% |
| Geode Capital Management, LLC | 365,002 | 0.82% | $82.51K | −88,389 | 0.00% |
| ADAR1 Capital Management, LLC | 351,141 | 0.79% | $79.36K | −400,000 | 0.00% |
| BlackRock, Inc. | 345,432 | 0.78% | $78.07K | −103,075 | 0.00% |
| Group One Trading, L.P. | 304,385 | 0.69% | $68.79K | +284,510 | 0.00% |
| Verdad Advisers, LP | 293,343 | 0.66% | $66.30K | +108,405 | 0.06% |
| Vanguard Fiduciary Trust Co | 217,700 | 0.49% | $49.20K | – | 0.00% |
| Jane Street Group, LLC | 164,827 | 0.37% | $37.25K | −107,984 | 0.00% |
| Boothbay Fund Management, LLC | 134,571 | 0.30% | $30.41K | – | 0.00% |
| State Street Corp | 121,114 | 0.27% | $27.37K | – | 0.00% |
| XTX Topco Ltd | 118,380 | 0.27% | $26.75K | −34,469 | 0.00% |
| Northern Trust Corp | 80,823 | 0.18% | $18.27K | +8,168 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 49 | 12M | 26.5% | 10 / 15 | 14 / 16 | 5M | 8M |
| Q1 2026 | 56 | 15M | 34.6% | 16 / 15 | 9 / 14 | 5M | 1M |
| Q4 2025 | 55 | 14M | 31.0% | 14 / 18 | 15 / 16 | 3M | 13M |
| Q3 2025 | 58 | 24M | 53.9% | 14 / 19 | 10 / 7 | 10M | 1M |
| Q2 2025 | 51 | 15M | 34.9% | 6 / 17 | 12 / 3 | 0M | 1M |
| Q1 2025 | 48 | 16M | 35.9% | 3 / 12 | 20 / 9 | 1M | 1M |
| Q4 2024 | 54 | 16M | 35.0% | 15 / 19 | 10 / 8 | 4M | 3M |
| Q3 2024 | 47 | 15M | 34.4% | 9 / 9 | 14 / 3 | 4M | 3M |
| Q2 2024 | 42 | 15M | 34.2% | 7 / 8 | 14 / 6 | 2M | 1M |
| Q1 2024 | 41 | 15M | 33.0% | 7 / 12 | 10 / 11 | 1M | 3M |
| Q4 2023 | 45 | 17M | 37.7% | 23 / 16 | 2 / 12 | 14M | 1M |
| Q3 2023 | 34 | 3M | 6.8% | 13 / 11 | 7 / 11 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of VTGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,160,455 | 2.61% | $262.26K | 0.00% | Jun 30, 2026 |
| AdvisorShares Psychedelics ETF | 438,643 | 0.99% | $99.13K | 0.22% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 413,745 | 0.93% | $93.51K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 266,141 | 0.60% | $167.67K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 48,903 | 0.11% | $30.81K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 46,961 | 0.11% | $29.59K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 12,189 | 0.03% | $7.68K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 4,947 | 0.01% | $1.12K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Shawn Singh | President and CEO, Director | 75,721 | 0.17% | Jul 2, 2026 |
| Nick B. Tressler | Chief Financial Officer | 11,712 | 0.03% | Jul 2, 2026 |
| Reid G. Adler | Chief Legal Officer | 60,868 | 0.14% | Jul 2, 2026 |
| Angel S. Angelov | Chief Medical Officer | – | – | May 19, 2026 |
| Joshua S. Prince | Chief Operating Officer | 15,249 | 0.03% | Apr 9, 2026 |
| Elissa S. Cote | Chief Corp Development Officer | – | – | Apr 9, 2026 |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | 12,801 | 0.03% | Jul 1, 2025 |
| Douglas J. Williamson | Director | – | – | Jul 31, 2026 |
| Paul R. Edick | Director | – | – | Nov 4, 2025 |
| Joanne Curley | Director | – | – | Sep 11, 2025 |
| Mary L. Rotunno | Director | – | – | Sep 11, 2025 |
| Ann Michelle Cunningham | Director | – | – | Sep 11, 2025 |
| Jon S. Saxe | Director | 55,751 | 0.13% | Sep 11, 2025 |
| Margaret M. FitzPatrick | Director | – | – | Sep 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Reid G. Adler Chief Legal Officer | Jun 30, 2026 | Award | +36,818 | $0.19 | $7.00K | 60,868 |
| Nick B. Tressler Chief Financial Officer | Jun 30, 2026 | Award | +11,712 | $0.19 | $2.23K | 11,712 |
| Shawn Singh President and CEO, Director | Jun 30, 2026 | Award | +36,818 | $0.19 | $7.00K | 54,846 |
| Joshua S. Prince Chief Operating Officer | Dec 31, 2025 | Award | +4,386 | $0.56 | $2.46K | 15,249 |
| Shawn Singh President and CEO, Director | Jun 30, 2025 | Award | +7,541 | $1.70 | $12.82K | 18,028 |
| Reid G. Adler Chief Legal Officer | Jun 30, 2025 | Award | +7,541 | $1.70 | $12.82K | 24,050 |
| Joshua S. Prince Chief Operating Officer | Jun 30, 2025 | Award | +4,882 | $1.70 | $8.30K | 10,863 |
| Cynthia Lynn Anderson CHIEF FINANCIAL OFFICER | Jun 30, 2025 | Award | +6,617 | $1.70 | $11.25K | 12,801 |
| Cynthia Lynn Anderson CHIEF FINANCIAL OFFICER | Dec 31, 2024 | Award | +2,592 | $2.51 | $6.51K | 6,184 |
| Joshua S. Prince Chief Operating Officer | Dec 31, 2024 | Award | +3,310 | $2.51 | $8.31K | 5,981 |
| Reid G. Adler CHF CORP DEVEL OFF, GEN COUNS | Jun 28, 2024 | Award | +4,854 | $2.96 | $14.37K | 16,509 |
| Joshua S. Prince Chief Operating Officer | Jun 28, 2024 | Award | +2,671 | $2.96 | $7.91K | 2,671 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Jun 28, 2024 | Award | +4,854 | $2.96 | $14.37K | 10,487 |
| Cynthia Lynn Anderson CHIEF FINANCIAL OFFICER | Jun 28, 2024 | Award | +3,592 | $2.96 | $10.63K | 3,592 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Dec 29, 2023 | Award | +167 | $1.72 | $287 | 5,633 |
| Reid G. Adler CHF CORP DEVEL OFF, GEN COUNS | Dec 29, 2023 | Award | +167 | $1.72 | $287 | 11,655 |
| Capital Lp Commodore 10% owner | Aug 7, 2023 | Buy | +775,756 | $23.15 | $17.96M | 1,575,000 |
| Jerrold Duane Dotson VP, CFO | Jun 30, 2023 | Award | +167 | $1.59 | $266 | 3,671 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Jun 30, 2023 | Award | +167 | $1.59 | $266 | 5,466 |
| Reid G. Adler CHIEF LEGAL OFFICER | Jun 30, 2023 | Award | +167 | $1.59 | $266 | 11,488 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Dec 30, 2022 | Award | +5,000 | $0.09 | $450 | 105,111 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Dec 30, 2022 | Award | +5,000 | $0.09 | $450 | 158,998 |
| Jerry B. Gin Director | Aug 18, 2022 | Buy | +100,000 | $0.18 | $18.00K | 100,000 |
| Jerry B. Gin Director | Aug 18, 2022 | Buy | +100,000 | $0.18 | $18.00K | 100,000 |
| Reid G. Adler CHIEF LEGAL OFFICER | Aug 17, 2022 | Buy | +300,000 | $0.17 | $51.00K | 334,629 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Aug 17, 2022 | Buy | +600,000 | $0.17 | $102.00K | 626,234 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jul 30, 2022 | Award | +5,000 | $0.75 | $3.75K | 100,111 |
| VHCP Management II, LLC 10% owner | Jul 12, 2022 | Sale | −60,000 | $0.89 | $53.40K | 20,637,286 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Jun 30, 2022 | Award | +5,000 | $0.75 | $3.75K | 153,998 |
| Mark Alan Smith CHIEF MEDICAL OFFICER | Jun 30, 2022 | Award | +5,000 | $0.75 | $3.75K | 19,915 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | May 12, 2022 | Option exercise | +100,000 | $1.00 | $100.00K | 148,998 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jan 11, 2022 | Option exercise | +18,750 | $1.00 | $18.75K | 94,571 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Dec 31, 2021 | Award | +3,623 | $1.66 | $6.01K | 48,998 |
| Mark Alan Smith CHIEF MEDICAL OFFICER | Dec 31, 2021 | Award | +2,655 | $1.66 | $4.41K | 14,915 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER | Dec 31, 2021 | Award | +3,623 | $1.66 | $6.01K | 64,958 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Dec 31, 2021 | Award | +3,575 | $1.66 | $5.93K | 75,821 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Sep 7, 2021 | Sale | −30,000 | $3.13 | $93.90K | 72,786 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER | Sep 2, 2021 | Gift | +1,111 | – | – | 61,335 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER | Aug 23, 2021 | Gift | −740 | – | – | 33,901 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER | Aug 17, 2021 | Buy | +3,750 | $2.73 | $10.24K | 34,641 |
| Mark Alan Smith CHIEF MEDICAL OFFICER | Jun 30, 2021 | Award | +2,260 | $1.95 | $4.41K | 12,260 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jun 30, 2021 | Award | +3,044 | $1.95 | $5.94K | 13,044 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jun 30, 2021 | Option exercise | +1,000 | $1.50 | $1.50K | 14,044 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jun 30, 2021 | Option exercise | +78,918 | $1.00 | $78.92K | 92,962 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jun 30, 2021 | Option exercise | +9,824 | $0.40 | $3.93K | 102,786 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Jun 30, 2021 | Award | +5,000 | $1.95 | $9.75K | 45,375 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER | Jun 30, 2021 | Award | +3,391 | $1.95 | $6.61K | 91,115 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Apr 23, 2021 | Option exercise | +5,000 | $1.50 | $7.50K | 40,375 |
| Jon S. Saxe Director | Mar 19, 2021 | Option exercise | +2,500 | $1.50 | $3.75K | 5,751 |
| Brian J. Underdown Director | Mar 19, 2021 | Option exercise | +2,500 | $1.50 | $3.75K | 2,500 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Dec 31, 2020 | Award | +5,000 | $0.45 | $2.25K | 35,375 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Dec 31, 2020 | Award | +5,000 | $0.45 | $2.25K | 10,000 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER, Director | Dec 31, 2020 | Award | +5,000 | $0.45 | $2.25K | 87,724 |
| Mark Alan Smith CHIEF MEDICAL OFFICER | Dec 31, 2020 | Award | +5,000 | $0.45 | $2.25K | 10,000 |
| Jon S. Saxe Director | Aug 21, 2020 | Buy | +30,000 | $0.69 | $20.70K | 50,000 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER, Director | Jun 30, 2020 | Award | +5,000 | $0.45 | $2.25K | 67,724 |
| Shawn Singh CHIEF EXECUTIVE OFFICER, Director | Jun 30, 2020 | Award | +5,000 | $0.45 | $2.25K | 30,375 |
| Mark Alan Smith CHIEF MEDICAL OFFICER | Jun 30, 2020 | Award | +5,000 | $0.45 | $2.25K | 5,000 |
| Jerrold Duane Dotson VP, CFO AND SECRETARY | Jun 30, 2020 | Award | +5,000 | $0.45 | $2.25K | 5,000 |
| 1415876 PRES./CHIEF SCIENTIFIC OFFICER, Director | Nov 20, 2019 | Buy | +15,000 | $0.34 | $5.10K | 15,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.